Your session is about to expire
← Back to Search
Butyrate Therapy for Type 1 Diabetes
Study Summary
This trial is looking at whether a colon-targeted 500 mg butyrate tablet can help with metabolic control in people with type 1 diabetes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there any more openings in this clinical examination?
"Clinicaltrials.gov evidences that this medical research is currently searching for volunteers; the initial posting was on July 28th 2022 and it has been recently updated on October 4th of the same year."
What demographic qualifies for enrollment in this research program?
"In order to qualify for this trial, individuals must have type 1 diabetes mellitus and be between 20-80 years old. Roughly 20 participants are required."
How many participants are being treated in this medical study?
"Affirmative. It is indicated on clinicaltrials.gov that this medical trial, posted on July 28th 2022 and revised most recently on October 4th 2022, is still recruiting patients with a need for 20 participants from one site."
Is geriatric patient inclusion a stipulation of this scientific research?
"The protocol for this experiment requires individuals between the ages of 20 and 80. There are 219 trials designed specifically for those under 18, while 921 cater to senior citizens over 65 years old."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Typically responds via
Share this study with friends
Copy Link
Messenger